PTC Therapeutics, Inc. Insider Transactions
PTC Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 200 @ $85.37 | $17.07 K | 100,625 | 11/25/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 862 @ $83.35 | $71.85 K | 101,094 | 11/25/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 180 @ $85.17 | $15.33 K | 100,625 | 11/25/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 3,095 @ $85.15 | $263.54 K | 100,625 | 11/25/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 689 @ $82.63 | $56.93 K | 101,956 | 11/25/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 13,514 @ $82.55 | $1.12 M | 134,735 | 11/25/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 4,715 @ $80.15 | $377.91 K | 100,625 | 11/24/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 21,206 @ $80.19 | $1.70 M | 100,625 | 11/24/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 1,650 @ $80.14 | $132.23 K | 100,625 | 11/24/2025 | 11/26/2025 | |
|
Jacobson Allan Steven
Director |
Sell | 5,701 @ $80.13 | $456.82 K | 17,451 | 11/24/2025 | 11/26/2025 | |
|
Jacobson Allan Steven
Director |
Sell | 6,100 @ $80.15 | $488.92 K | 17,451 | 11/24/2025 | 11/26/2025 | |
|
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER |
Sell | 6,101 @ $80.17 | $489.12 K | 100,625 | 11/24/2025 | 11/26/2025 | |
|
Reeve Emma
Director |
Sell | 10,000 @ $79.50 | $795.00 K | 6,666 | 11/21/2025 | 11/25/2025 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 192 @ $77.18 | $14.82 K | 103,901 | 11/17/2025 | 11/19/2025 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 777 @ $76.53 | $59.46 K | 104,093 | 11/17/2025 | 11/19/2025 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 1,843 @ $75.64 | $139.41 K | 104,870 | 11/17/2025 | 11/19/2025 | |
|
Reeve Emma
Director |
Sell | 7,333 @ $74.50 | $546.31 K | 6,666 | 11/12/2025 | 11/14/2025 | |
|
Reeve Emma
Director |
Sell | 12,000 @ $69.50 | $834.00 K | 6,666 | 10/30/2025 | 10/31/2025 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 1,306 @ $63.80 | $83.32 K | 104,213 | 10/07/2025 | 10/09/2025 | |
|
Boulding Mark Elliott
EXEC. VP AND CLO |
Sell | 312 @ $64.97 | $20.27 K | 103,901 | 10/07/2025 | 10/09/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PTC Therapeutics, Inc. FAQ's
The list of insiders at PTC Therapeutics, Inc. includes Boulding Mark Elliott, Gravier Pierre, Klein Matthew B., Jacobson Allan Steven, Pauwels Eric, SOUTHWELL DAVID P, Reeve Emma, Almstead Neil Gregory.
Insiders have sold a total of 375.10 K PTC Therapeutics, Inc. shares in the last 12 months for a total of 26.34 M sold.
The following insiders have sold PTC Therapeutics, Inc. shares in the last 12 months: Boulding Mark Elliott ($3.95 M), Gravier Pierre ($124.44 K), Klein Matthew B. ($555.64 K), Jacobson Allan Steven ($3.00 M), Pauwels Eric ($1.57 M), SOUTHWELL DAVID P ($700.08 K), Reeve Emma ($4.12 M), Almstead Neil Gregory ($12.32 M),